Oyster Bay, New York - 25 Jul 2014
Alere Connect, Qualcomm Life, and Preventice ranked one, two and three respectively in ABI Research’s latest “Remote Patient Management Platforms” Competitive Assessment. The study assessed remote patient monitoring platforms that connect to wearable wireless-enabled healthcare devices across criteria placed in two broad categories: Innovation and Implementation.
The results of this vendor matrix reflect the transition taking place in this market. By and large the companies that scored highest in the Innovation segment did less well in the Implementation segment and vice versa as the market shifts from vertically integrated platforms and devices to more open platform offerings.
Qualcomm Life topped the Innovation category. Coming from outside the medical space and with a platform play that looks to be a free-standing business and not an accessory to a single vendor wearable mhealth device, the platform typifies many of the attributes that will increasingly drive acceptance and adoption of remote patient monitoring platforms. Alere Connect was ranked second, boosted by its platform and gateway support for a device from multiple vendors. Third in Innovation was Vivify Health, a smaller player but one with some additional innovative features including support for videoconferencing.
Within the Implementation category, Alere Connect won the top spot driven by subscriber growth, integration with a range of Alere services, and the company’s growing international reach. It was followed by Preventice, a company with a far more focused offering, but one that supports its own wearable wireless device and smartphone integration. In third place was Medtronic, which scored well due to the quality of its recently acquired companies that specialize in RPM services.In the space of a year, Medtronic has acquired Cardiocom, Corventis and has a pending deal for Covidien.
Principal analyst, Jonathan Collins commented, “An important aspect of this Competitive Assessment was evaluating each vendor’s efforts and current ability to integrate a range of devices, applications and eco-system partners on their platform. Remote patient management platforms will increasingly have to be flexible to draw in the largest possible number of end-users and devices without the need for lengthy and expensive customization. However, longevity and trusted credentials in the healthcare market will also play a factor and these aspects were carefully considered as well.”
These findings are part of ABI Research’s mHealth Wearables, Platforms and Services Market Research.
ABI Research provides in-depth analysis and quantitative forecasting of trends in global connectivity and other emerging technologies. From offices in North America, Europe and Asia, ABI Research’s worldwide team of experts advises thousands of decision makers through 70+ research and advisory services. Est. 1990. For more information visit www.abiresearch.com, or call +1.516.624.2500.
About ABI Research
ABI Research provides strategic guidance to visionaries, delivering actionable intelligence on the transformative technologies that are dramatically reshaping industries, economies, and workforces across the world. ABI Research's global team of analysts publish groundbreaking studies often years ahead of other technology advisory firms, empowering our clients to stay ahead of their markets and their competitors.
ABI Research提供开创性的研究和战略指导，帮助客户了解日新月异的技术。 自1990年以来，我们已与全球数百个领先的技术品牌，尖端公司，具有远见的政府机构以及创新的贸易团体建立了合作关系。 我们帮助客户创造真实的业务成果。
For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com.
Asia: +65 6950.5670